News

Mon, 06/13/2022 - 09:30

The I-SPARC study

News :13/06/2022 Do you want to contribute to research to combat the Coronavirus (COVID-19) among cancer patients? The I-SPARC study
The I-SPARC clinical trial aims to evaluate the immune response among cancer patients after administering at least two doses and possibly a booster dose of an RNA messenger vaccine against COVID-19 (Pfizer/BioNTech vaccine or Moderna vaccine).*    This international clinical trial is being…
(read more)

Thu, 06/09/2022 - 09:50

Bordet’n Family

Bordet’n Family: a space for listening and support for families facing cancerA cancer diagnosis and its treatments can disrupt family balance. Children and teenagers who are confronted with the illness of a loved one may experience emotional, academic, or social difficulties. Parents and relatives often have many questions about how best to support their children and teenagers in the context of cancer.To help families better cope with the impact…
(read more)

Mon, 05/30/2022 - 09:19

Impulsion by Bordet: the team of athlete patients

Press release (30/05/2022)  Impulsion by Bordet: the team of athlete patients 30 May 2022 – This 29 May, at the starting line for the Brussels 20km, among the crowd of runners, there was a very special team: Impulsion by Bordet. All members of this team are or were patients at the Jules Bordet Institute, the reference centre for integrated cancer care in Belgium. At the impulsion of oncologists and physiotherapists, they have been…
(read more)

Thu, 05/12/2022 - 08:54

Les Veilleuses / Night Lights

Communiqué de presse 12/05/2022 « Les Veilleuses / Night Lights » pour parler des hôpitaux autrement
L’H.U.B. réitère sa collaboration unique entre artistes et personnel soignant  Bruxelles, le 10/05/2022 - Le 12 mai 2022, Journée internationale des infirmières et infirmiers, l’Hôpital universitaire de Bruxelles (H.U.B.), regroupant l’Hôpital Erasme, l’Institut Jules Bordet et l’Hôpital universitaire des enfants Reine…
(read more)

Thu, 04/28/2022 - 09:19

The Jules Bordet Institute opens its Radiotheranostics Centre of Excellence

Press release (28/04/2022)  The Jules Bordet Institute opens its Radiotheranostics Centre of Excellence A new era in treating and diagnosing patients in Nuclear Medicine 28 April 2022 – Wednesday 27 April 2022, the Jules Bordet Institute officially opened its "Radiotheranostics Centre of Excellence" in its Department of Nuclear Medicine. An innovative form of targeted drug therapy in fighting cancer, radiotheranostics is today a…
(read more)

Fri, 03/18/2022 - 08:50

Covid-19 informations

Visits to patients are allowed subject to certain conditions. Persons accompanying out-patients (consultations and technical medical procedures) are allowed CLICK HERE FOR MORE INFORMATION
(read more)

Thu, 03/03/2022 - 09:15

The RESTART programme

News (03/03/2022) The RESTART programme: personalised follow-up for persons with breast cancer in remission.   The RESTART programme offers patients with breast cancer in remission a multidisciplinary and personalised follow-up that combines consultations, physical activities, physiotherapy and educational workshops. The first patients joined the project at the beginning of January 2022 and have participated in the first…
(read more)

Mon, 02/14/2022 - 08:50

Objective 20 KM

News : 14/02/2022 25 patients at the Jules Bordet Institute accompanied by care staff will be taking up the challenge and competing in the Brussels 20 km. 

Who said that cancer and sport are incompatible? Certainly not us!  Discover the project  
(read more)

Mon, 02/07/2022 - 08:00

PAtient CEntricity Award de la Belgian Hematology Society

News (07/02/2022) The Jules Bordet Institute Hematology Department honoured with PAtient CEntricity Award from the Belgian Hematology Society. This Saturday 5 February 2022, the Institute's Hematology Department was honoured with the PACE Award and a grant of 10 000 euros for its project for a multidisciplinary approach to managing pain caused by drugs administered to treat multiple myeloma.


Dr. Marie Vercruyssen, hematologist…
(read more)

Fri, 02/04/2022 - 09:19

4 February = World Cancer Day

Press release (04/02/2022)  4 February = World Cancer Day DECRESCENDO, a new large clinical trial to test a less intensive chemotherapy treatment for patients with HER2-positive breast cancer Brussels (Belgium), 4 February 2022 - A new international clinical study was recently
opened in France and Belgium – with the first patient enrolled on 17 January – to assess
if it is possible to give a less intensive chemotherapy…
(read more)